Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | NT5E | P21589 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | PTPRZ1 | P23471 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 6/20 | 0.36 |
| ▸ | CA1 | P00915 | 4/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | CA4 | P22748 | 2/20 | 0.36 |
| ▸ | CA6 | P23280 | 2/20 | 0.36 |
| ▸ | CA5A | P35218 | 2/20 | 0.36 |
| ▸ | CA7 | P43166 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL778371 | 0.84 | TSHR (0.47) | TSHRALDH1A1NT5ELMNASMN1; SMN2 | |
| SCHEMBL28608045 | 0.81 | TSHR (0.48) | TSHRALDH1A1NT5ELMNASMN1; SMN2 | |
| SCHEMBL28616318 | 0.81 | TSHR (0.44) | TSHRALDH1A1NT5ELMNASMN1; SMN2 | |
| SCHEMBL777060 | 0.81 | TSHR (0.44) | TSHRALDH1A1NT5ELMNASMN1; SMN2 | |
| SCHEMBL29001852 | 0.81 | ALDH1A1 (0.52) | TSHRALDH1A1NT5ELMNASMN1; SMN2 | |
| SCHEMBL778771 | 0.80 | LMNA (0.43) | TSHRALDH1A1NT5ELMNASMN1; SMN2 | |
| SCHEMBL777272 | 0.80 | TSHR (0.42) | TSHRALDH1A1NT5ELMNASMN1; SMN2 | |
| SCHEMBL1415708 | 0.79 | ALDH1A1 (0.43) | TSHRALDH1A1TDP1CYP2D6PTPRZ1 | |
| SCHEMBL6536459 | 0.79 | LCK (0.38) | TSHRALDH1A1NT5ELMNASMN1; SMN2 | |
| SCHEMBL11100709 | 0.79 | ESR1 (0.54) | TSHRALDH1A1NT5ELMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107629050-A | A kind of synthetic method of pyranone compounds of the novel imidazole class containing chalcogen | 河南工业大学 | 2018-01-26 | — | — | CN | claimed |
| US-20230203086-A1 | RIBONUCLEIC ACID PURIFICATION | ARES CAPITAL CORPORATION, AS AGENT | 2023-06-29 | — | — | US | disclosed |
| US-11377470-B2 | Ribonucleic acid purification | MODERNATX, INC. (US) | 2022-07-05 | — | — | US | disclosed |
| CN-108129348-A | Nitrine trifluoromethoxy compound and its synthetic method | 南开大学 | 2018-06-08 | — | — | CN | disclosed |
| US-9343777-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2016-05-17 | — | — | US | disclosed |
| US-9252457-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2016-02-02 | — | — | US | disclosed |
| US-20160024140-A1 | RIBONUCLEIC ACID PURIFICATION | ARES CAPITAL CORPORATION, AS AGENT | 2016-01-28 | — | — | US | disclosed |
| US-20160024140-A1 | RIBONUCLEIC ACID PURIFICATION | ARES CAPITAL CORPORATION, AS AGENT | 2016-01-28 | — | — | US | disclosed |
| US-20120177988-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-07-12 | — | — | US | disclosed |
| US-20120070731-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-03-22 | — | — | US | disclosed |
| US-20090325065-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2009-12-31 | — | — | US | disclosed |
| US-6544717-B2 | Antireflective coating | TOKYO OHKA KOGYO CO., LTD. (JP) | 2003-04-08 | — | — | US | disclosed |
| US-20010049072-A1 | Undercoating composition for photolithographic resist | HIROSAKI TAKAKO (JP) | 2001-12-06 | — | — | US | disclosed |
| US-6284428-B1 | FOR FORMING OF ANTIREFLECTION UNDERCOATING LAYER TO INTERVENE BETWEEN SURFACE OF SUBSTRATE AND PHOTORESIST LAYER TO BE PATTERNED IN MANUFACTURING PROCESS OF SEMICONDUCTOR DEVICES | TOKYO OHKA KOGYO CO., LTD, (JP) | 2001-09-04 | — | — | US | disclosed |
| US-20010018163-A1 | Undercoating composition for photolithographic resist | TOKYO OHKA KOGYO CO., LTD. (JP) | 2001-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230203086-A1 | RIBONUCLEIC ACID PURIFICATION | TRDMT1, POLI, NOP2 | TSHR 751/4885ALDH1A1 2932/4885NT5E 173/4885 |
| US-11377470-B2 | Ribonucleic acid purification | TRDMT1, POLI, NOP2 | TSHR 751/4885ALDH1A1 2932/4885NT5E 173/4885 |
| US-20160024140-A1 | RIBONUCLEIC ACID PURIFICATION | TRDMT1, POLI, NOP2 | TSHR 751/4885ALDH1A1 2932/4885NT5E 173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.